Top Markets
#1 Pleasing Gold Pleasing Gold +1,542.01%
#2 PulseChain PulseChain +58.48%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.90%
#4 BOOK OF MEME BOOK OF MEME +31.87%
#5 Ontology Gas Ontology Gas +23.58%
#6 Nockchain Nockchain +22.84%
#7 Pump.fun Pump.fun +22.48%
#8 Unit Pump Unit Pump +22.48%
#9 Neiro Neiro +21.27%
#10 SkyAI SkyAI +20.01%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Ambalal Sarabhai Enterprises Limited Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Limited

AMBALALSA
Rank in Stocks #26496
Ambalal Sarabhai Enterprises Ltd. operates as a holding company with... Ambalal Sarabhai Enterprises Ltd. operates as a holding company with investments across the pharmaceutical and electrical industries. Its core activities include the production and marketing of pharmaceutical goods. The company was established on June 27, 1977, and its principal office is located in Ahmedabad, India.
Share Price
$0.52431453
Market Cap
$40.18M
Change (1 day)
2.15%
Change (1 year)
33.33%
Country
IN
Trade Ambalal Sarabhai Enterprises Limited (AMBALALSA)

Category

Healthcare
Earnings for Ambalal Sarabhai Enterprises Limited (AMBALALSA)
Earnings in 2026 TTM: 0
According to Ambalal Sarabhai Enterprises Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Ambalal Sarabhai Enterprises Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT